C/EBPβ is required for 'emergency' granulopoiesis

Metcalf, D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254, 529–533 (1991).

Tenen, D.G., Hromas, R., Licht, J.D. & Zhang, D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519 (1997).

Zhu, J. & Emerson, S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21, 3295–3313 (2002).

Cheers, C. et al. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 56, 247–251 (1988).

Watari, K. et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73, 117–122 (1989).

Metcalf, D. & Nicola, N.A. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J. Cell. Physiol. 116, 198–206 (1983).

Liu, F., Wu, H.Y., Wesselschmidt, R., Kornaga, T. & Link, D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491–501 (1996).

Lieschke, G.J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737–1746 (1994).

Metcalf, D. et al. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 68, 46–57 (1986).

Metcalf, D. et al. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 15, 1–9 (1987).

Nishinakamura, R. et al. Mice deficient for the IL-3/GM-CSF/IL-5 β c receptor exhibit lung pathology and impaired immune response, while β IL3 receptor-deficient mice are normal. Immunity 2, 211–222 (1995).

Landschulz, W.H., Johnson, P.F. & McKnight, S.L. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243, 1681–1688 (1989).

Smith, L.T., Hohaus, S., Gonzalez, D.A., Dziennis, S.E. & Tenen, D.G.P.U. 1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88, 1234–1247 (1996).

Ford, A.M. et al. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBPα, -β and -δ during granulocyte-lineage specification. Proc. Natl. Acad. Sci. USA 93, 10838–10843 (1996).

Oelgeschlager, M., Nuchprayoon, I., Luscher, B. & Friedman, A.D. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16, 4717–4725 (1996).

Radomska, H.S. et al. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301–4314 (1998).

Zhang, D.E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569–574 (1997).

Zhang, P. et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21, 853–863 (2004).

Yamanaka, R. et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ε-deficient mice. Proc. Natl. Acad. Sci. USA 94, 13187–13192 (1997).

Natsuka, S. et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79, 460–466 (1992).

Scott, L.M., Civin, C.I., Rorth, P. & Friedman, A.D. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80, 1725–1735 (1992).

Screpanti, I. et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice. EMBO J. 14, 1932–1941 (1995).

Tanaka, T. et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353–361 (1995).

Sterneck, E., Tessarollo, L. & Johnson, P.F. An essential role for C/EBPβ in female reproduction. Genes Dev. 11, 2153–2162 (1997).

Sterneck, E. et al. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein δ. Proc. Natl. Acad. Sci. USA 95, 10908–10913 (1998).

Zhang, P. et al. Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein α (C/EBPα) is critical for granulopoiesis. J. Exp. Med. 188, 1173–1184 (1998).

Collins, S.J., Ulmer, J., Purton, L.E. & Darlington, G. Multipotent hematopoietic cell lines derived from C/EBPα−/− knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte-colony-stimulating factor, and retinoic acid-induced granulocytic differentiation. Blood 98, 2382–2388 (2001).

Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258–1266 (1999).

Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193–199 (1991).

Jiang, J., Yamato, E. & Miyazaki, J. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression. Biochem. Biophys. Res. Commun. 289, 1088–1092 (2001).

Akashi, K., Traver, D., Miyamoto, T. & Weissman, I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197 (2000).

Wang, N.D. et al. Impaired energy homeostasis in C/EBPα knockout mice. Science 269, 1108–1112 (1995).

Zhang, P. et al. Induction of granulocytic differentiation by 2 pathways. Blood 99, 4406–4412 (2002).

Basu, S. et al. “Emergency” granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95, 3725–3733 (2000).

Begay, V., Smink, J. & Leutz, A. Essential requirement of CCAAT/enhancer binding proteins in embryogenesis. Mol. Cell. Biol. 24, 9744–9751 (2004).

Sutherland, J.A., Turner, A.R., Mannoni, P., McGann, L.E. & Turc, J.M. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Response Mod. 5, 250–262 (1986).

Duprez, E., Wagner, K., Koch, H. & Tenen, D.G. C/EBPβ: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J. 22, 5806–5816 (2003).

Ross, S.E. et al. Phosphorylation of C/EBPα inhibits granulopoiesis. Mol. Cell. Biol. 24, 675–686 (2004).

Wang, Q.F., Cleaves, R., Kummalue, T., Nerlov, C. & Friedman, A.D. Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis. Oncogene 22, 2548–2557 (2003).

Johansen, L.M. et al. c-Myc is a critical target for c/EBPα in granulopoiesis. Mol. Cell. Biol. 21, 3789–3806 (2001).

Descombes, P., Chojkier, M., Lichtsteiner, S., Falvey, E. & Schibler, U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 4, 1541–1551 (1990).

Poli, V., Mancini, F.P. & Cortese, R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643–653 (1990).

Akira, S. et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897–1906 (1990).

Wang, Q.F. & Friedman, A.D. CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor. Blood 99, 2776–2785 (2002).

Popernack, P.M., Truong, L.T., Kamphuis, M. & Henderson, A.J. Ectopic expression of CCAAT/enhancer binding protein beta (C/EBPβ) in long-term bone marrow cultures induces granulopoiesis and alters stromal cell function. J. Hematother. Stem Cell Res. 10, 631–642 (2001).

Jones, L.C. et al. Expression of C/EBPβ from the C/ebpα gene locus is sufficient for normal hematopoiesis in vivo. Blood 99, 2032–2036 (2002).

Trautwein, C. et al. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364, 544–547 (1993).

Buck, M., Poli, V., van der Geer, P., Chojkier, M. & Hunter, T. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα. Mol. Cell 4, 1087–1092 (1999).

Hsu, C.L. et al. Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc. Natl. Acad. Sci. USA 103, 672–677 (2006).

McKnight, S.L. McBindalla–better name for CCAAT/enhancer binding proteins? Cell 107, 259–261 (2001).

Wang, H. et al. C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol. Cell 8, 817–828 (2001).

Porse, B.T. et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107, 247–258 (2001).

Xie, H., Ye, M., Feng, R. & Graf, T. Stepwise reprogramming of B cells into macrophages. Cell 117, 663–676 (2004).

Greenbaum, L.E. et al. CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 102, 996–1007 (1998).

Nerlov, C. C/EBPα mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4, 394–400 (2004).

Pabst, T. et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nat. Med. 7, 444–451 (2001).

Perrotti, D. et al. BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2. Nat. Genet. 30, 48–58 (2002).

Guibal, F., Radomska, H.S., Johansen, L.M. & Tenen, D.G. C/EBP is deregulated by PML-RAR in acute promyelocytic leukemia. Blood 106, 844 (2005).

Radomska, H.S. et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J. Exp. Med. 203, 371–381 (2006).

Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063–1066 (2000).